Baker Biotech Capital II (Z) (GP), LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Biotech Capital II (Z) (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Biotech Capital II (Z) (GP), LLC. Baker Biotech Capital II (Z) (GP), LLC is 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).

Latest Insider Trading Transactions of Baker Biotech Capital II (Z) (GP), LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, IBPI, SGEN, VPHM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	20.41	5,169	105,504	103,540	108.7 K to 103.5 K (-4.75 %)
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	19.90	10,508	209,060	108,709	119.2 K to 108.7 K (-8.81 %)
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	21.81	30	654	119,217	119.2 K to 119.2 K (-0.03 %)
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	21.58	1,606	34,657	119,247	120.9 K to 119.2 K (-1.33 %)
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	21.72	7,165	155,654	120,853	128 K to 120.9 K (-5.60 %)
Mar 01 2006	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Sell	S	21.74	7,080	153,940	128,018	135.1 K to 128 K (-5.24 %)
May 12 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	19,000	47,500	315,000
May 12 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Buy	P	2.65	45	119	799	754 to 799 (+5.97 %)
May 12 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Buy	P	1.79	370	662	754	384 to 754 (+96.35 %)
May 04 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	109.15	57,000	6,221,550	227,000
Apr 22 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	109.15	56,000	6,112,400	170,000
Apr 22 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	109.15	38,000	4,147,700	114,000
Apr 18 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	10,000	25,000	296,000
Apr 14 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	109.15	76,000	8,295,400	76,000
May 06 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.79	948	4,541	49,807	48.9 K to 49.8 K (+1.94 %)
Apr 01 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.96	1,506	7,474	37,317	35.8 K to 37.3 K (+4.21 %)
Apr 14 2005	IBPI	Ardea Biosciences, ...	Baker Biotech Capital II (Z) ( ...	10% Owner	Buy	P	3.57	193	689	49,200	49 K to 49.2 K (+0.39 %)
Mar 02 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	42,000	105,000	286,000
Mar 02 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	19,000	47,500	244,000
Mar 02 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	47,000	117,500	225,000
Feb 14 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	19,000	47,500	178,000
Feb 14 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	57,000	142,500	159,000
Feb 14 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Option Exercise	P	2.50	26,000	65,000	102,000
Feb 14 2005	VPHM	VIROPHARMA INC	Baker Biotech Capital II (Z) ( ...	10% Owner	Buy	P	3.02	384	1,159	384	0 to 384
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.90	826	4,047	35,811	35 K to 35.8 K (+2.36 %)
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.81	346	1,666	34,985	34.6 K to 35 K (+1.00 %)
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.90	113	554	34,639	34.5 K to 34.6 K (+0.33 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.96	9,919	49,193	34,526	24.6 K to 34.5 K (+40.31 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.99	7	35	24,607	24.6 K to 24.6 K (+0.03 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	5.04	10,329	52,024	24,600	14.3 K to 24.6 K (+72.38 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital II (Z) ( ...	Director	Buy	P	4.88	729	3,557	14,271	13.5 K to 14.3 K (+5.38 %)

Page: 1